Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
Navrogen's investors include Ben Franklin Technology Partners of Southeastern Pennsylvania, National Cancer Institute, Tellus BioVentures.
Navrogen is headquartered in Philadelphia, United States.
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
Navrogen is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Navrogen — Funding & Investors." VCBacked, September 8, 2025, https://www.vcbacked.co/company/navrogen. Accessed September 29, 2026.
VCBacked. (2025). Navrogen — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/navrogen
{{cite web |title=Navrogen — Funding & Investors |url=https://www.vcbacked.co/company/navrogen |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated